Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents.

Jang TY, Huang CI, Yeh ML, Liang PC, Tsai PC, Lin YH, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Huang JF, Dai CY, Huang CF, Chuang WL, Yu ML.

J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14835. [Epub ahead of print]

PMID:
31414504
2.

Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.

Yeh ML, Huang CF, Huang CI, Dai CY, Lin IH, Liang PC, Hsieh MH, Lin ZY, Chen SC, Huang JF, Chen JJ, Yu ML, Chuang WL.

PLoS One. 2019 Aug 8;14(8):e0220663. doi: 10.1371/journal.pone.0220663. eCollection 2019.

3.

Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir.

Huang CF, Yeh ML, Huang CI, Liang PC, Lin YH, Hsieh MY, Chen KY, Ko YM, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML.

J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14815. [Epub ahead of print]

PMID:
31373037
4.

Higher NAFLD fibrosis score is associated with impaired eGFR.

Hsieh MH, Wu KT, Chen YY, Yang JF, Lin WY, Chang NC, Lin CY, Huang CK, Wang CL, Chuang HY, Lin SC, Hsu YK, Tsai YS, Chuang WL, Yu ML, Dai CY.

J Formos Med Assoc. 2019 Jul 25. pii: S0929-6646(19)30160-3. doi: 10.1016/j.jfma.2019.07.007. [Epub ahead of print]

5.

Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex.

Wang CW, Chuang HY, Liao KW, Yu ML, Dai CY, Chang WT, Tsai CH, Chiang HC, Huang PC.

Environ Int. 2019 Oct;131:104978. doi: 10.1016/j.envint.2019.104978. Epub 2019 Jul 18.

6.

The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment.

Yeh ML, Huang CF, Huang CI, Hsieh MY, Hou NJ, Lin IH, Liang PC, Tsai YS, Hsieh MH, Lin ZY, Chen SC, Dai CY, Huang JF, Yu ML, Chuang WL.

Kaohsiung J Med Sci. 2019 Jun 28. doi: 10.1002/kjm2.12105. [Epub ahead of print]

7.

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.

Perez S, Kaspi A, Domovitz T, Davidovich A, Lavi-Itzkovitz A, Meirson T, Alison Holmes J, Dai CY, Huang CF, Chung RT, Nimer A, El-Osta A, Yaari G, Stemmer SM, Yu ML, Haviv I, Gal-Tanamy M.

PLoS Genet. 2019 Jun 19;15(6):e1008181. doi: 10.1371/journal.pgen.1008181. eCollection 2019 Jun.

8.

Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.

Hsu CC, Hsieh PM, Chen YS, Lo GH, Lin HY, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML, Lin CW.

Cancer Med. 2019 Jul;8(7):3453-3463. doi: 10.1002/cam4.2229. Epub 2019 May 16.

9.

Integrated care for methadone maintenance patients with hepatitis C virus infection.

Tai CM, Yen YC, Bair MJ, Tseng CH, Chang TT, Huang CF, Yeh ML, Dai CY, Chuang WL, Yu ML, Huang JF.

Kaohsiung J Med Sci. 2019 Aug;35(8):501-507. doi: 10.1002/kjm2.12086. Epub 2019 May 14.

10.

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study.

Huang CF, Yeh ML, Huang CI, Liang PC, Lin YH, Hsieh MY, Wei YJ, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML.

BMJ Open. 2019 May 5;9(5):e026703. doi: 10.1136/bmjopen-2018-026703.

11.

Prevalence of Persistent Tinnitus and Dizziness in an Elderly Population in Southern Taiwan.

Chang NC, Dai CY, Lin WY, Yang HL, Wang HM, Chien CY, Ho KY.

J Int Adv Otol. 2019 Apr;15(1):99-105. doi: 10.5152/iao.2019.6257.

12.

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.

Jun T, Hsu YC, Ogawa S, Huang YT, Yeh ML, Tseng CH, Huang CF, Tai CM, Dai CY, Huang JF, Chuang WL, Yu ML, Tanaka Y, Nguyen MH.

Hepatol Commun. 2019 Feb 8;3(4):493-503. doi: 10.1002/hep4.1321. eCollection 2019 Apr.

13.

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.

Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML.

J Infect Dis. 2019 Apr 8. pii: jiz154. doi: 10.1093/infdis/jiz154. [Epub ahead of print]

PMID:
30957170
14.

Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.

Huang JF, Tsai PC, Yeh ML, Huang CF, Huang CI, Hsieh MH, Dai CY, Yang JF, Chen SC, Yu ML, Chuang WL, Chang WY.

J Formos Med Assoc. 2019 Apr 2. pii: S0929-6646(19)30005-1. doi: 10.1016/j.jfma.2019.03.014. [Epub ahead of print]

15.

Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C.

Batsaikhan B, Lu MY, Yeh ML, Huang CI, Huang CF, Lin ZY, Chen SC, Huang JF, Hsieh PH, Chuang WL, Lee JC, Yu ML, Dai CY.

J Chin Med Assoc. 2019 Apr;82(4):277-281. doi: 10.1097/JCMA.0000000000000064.

PMID:
30946707
16.

5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.

Yang BY, Jiang CY, Dai CY, Zhao RZ, Wang XJ, Zhu YP, Qian YX, Yin FL, Fu XY, Jing YF, Han BM, Xia SJ, Ruan Y.

Cell Prolif. 2019 May;52(3):e12590. doi: 10.1111/cpr.12590. Epub 2019 Mar 18.

PMID:
30883989
17.

Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients.

Batsaikhan B, Gantumur G, Huang CI, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL, Lee JC, Dai CY.

J Chin Med Assoc. 2019 Feb;82(2):99-104. doi: 10.1097/JCMA.0000000000000009.

PMID:
30839498
18.

Porous Se@SiO2 nanosphere-coated catheter accelerates prostatic urethra wound healing by modulating macrophage polarization through reactive oxygen species-NF-κB pathway inhibition.

Yang BY, Deng GY, Zhao RZ, Dai CY, Jiang CY, Wang XJ, Jing YF, Liu XJ, Xia SJ, Han BM.

Acta Biomater. 2019 Apr 1;88:392-405. doi: 10.1016/j.actbio.2019.02.006. Epub 2019 Feb 10.

PMID:
30753941
19.

Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients.

Yeh ML, Huang CI, Huang CF, Hsieh MH, Liu TW, Lin YH, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang JF, Kuo PL, Dai CY, Yu ML, Chuang WL.

J Infect Dis. 2019 Apr 8;219(8):1224-1233. doi: 10.1093/infdis/jiy648.

PMID:
30452671
20.

Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals.

Huang CF, Yeh ML, Huang CI, Liang PC, Lin YH, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML.

Hepatol Int. 2018 Nov;12(6):544-551. doi: 10.1007/s12072-018-9908-4. Epub 2018 Nov 13.

PMID:
30426395
21.

Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?

Huang JF, Huang CF, Yeh ML, Dai CY, Yu ML, Chuang WL.

Expert Rev Anti Infect Ther. 2018 Dec;16(12):907-912. doi: 10.1080/14787210.2018.1544492. Epub 2018 Nov 9. Review.

PMID:
30396303
22.

Association of hyperuricemia with disease severity in chronic hepatitis C patients.

Jang TY, Yeh ML, Huang CI, Lin ZY, Chen SC, Hsieh MH, Dai CY, Huang JF, Huang CF, Chuang WL, Yu ML.

PLoS One. 2018 Nov 5;13(11):e0207043. doi: 10.1371/journal.pone.0207043. eCollection 2018.

23.

Fulminant Emphysematous Pancreatic Pseudocyst: Infected with Normal Skin Flora.

Wang CW, Dai CY, Chuang TM, Huang CF, Yeh ML, Huang CI, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL.

Am J Med. 2019 Feb;132(2):e41-e42. doi: 10.1016/j.amjmed.2018.10.001. Epub 2018 Oct 25. No abstract available.

PMID:
30367856
24.

Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection.

Huang CF, Wang SC, Chang WT, Yeh ML, Huang CI, Lin ZY, Chen SC, Chuang WL, Huang JF, Dai CY, Chen YL, Yu ML.

Sci Rep. 2018 Oct 25;8(1):15821. doi: 10.1038/s41598-018-34155-7.

25.

Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies.

Lin TY, Yeh ML, Huang CF, Huang CI, Dai CY, Hsieh MH, Chen SC, Huang JF, Yu ML, Chuang WL.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):224-229. doi: 10.1097/MEG.0000000000001285.

PMID:
30308578
26.

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals.

Huang CF, Yeh ML, Huang CI, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chen JJ, Yu ML.

Sci Rep. 2018 Oct 10;8(1):15058. doi: 10.1038/s41598-018-33448-1.

27.

Optimization of Flavonoids Extraction Process in Panax notoginseng Stem Leaf and a Study of Antioxidant Activity and Its Effects on Mouse Melanoma B16 Cells.

Dai CY, Liu PF, Liao PR, Qu Y, Wang CX, Yang Y, Cui XM.

Molecules. 2018 Sep 1;23(9). pii: E2219. doi: 10.3390/molecules23092219.

28.

iTRAQ-based proteomics screen for potential regulators of wheat (Triticum aestivum L.) root cell wall component response to Al stress.

Yang Y, Ma L, Zeng H, Chen LY, Zheng Y, Li CX, Yang ZP, Wu N, Mu X, Dai CY, Guan HL, Cui XM, Liu Y.

Gene. 2018 Oct 30;675:301-311. doi: 10.1016/j.gene.2018.07.008. Epub 2018 Jul 3.

PMID:
30180969
29.

Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.

Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Bair MJ, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML.

PLoS One. 2018 Sep 4;13(9):e0202650. doi: 10.1371/journal.pone.0202650. eCollection 2018.

30.

The Association of GRM7 Single Nucleotide Polymorphisms with Age-Related Hearing Impairment in a Taiwanese Population.

Chang NC, Dai CY, Lin WY, Yang HL, Wang HM, Chien CY, Hsieh MH, Ho KY.

J Int Adv Otol. 2018 Aug;14(2):170-175. doi: 10.5152/iao.2018.5109.

31.

Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.

Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Chou TC, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML.

Clin Transl Gastroenterol. 2018 Jul 2;9(6):166. doi: 10.1038/s41424-018-0033-4.

32.

Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.

Huang CF, Wang SC, Yeh ML, Huang CI, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Chen A, Yu ML.

J Gastroenterol Hepatol. 2019 Jan;34(1):249-255. doi: 10.1111/jgh.14359. Epub 2018 Jul 10.

PMID:
29932235
33.

A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders.

Tsai PC, Liu TW, Huang CF, Yeh ML, Dai CY, Chuang WL, Huang JF, Yu ML.

J Chin Med Assoc. 2018 Aug;81(8):670-675. doi: 10.1016/j.jcma.2017.05.015. Epub 2018 Jun 1.

34.

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.

Chen VL, Yeh ML, Le AK, Jun M, Saeed WK, Yang JD, Huang CF, Lee HY, Tsai PC, Lee MH, Giama N, Kim NG, Nguyen PP, Dang H, Ali HA, Zhang N, Huang JF, Dai CY, Chuang WL, Roberts LR, Jun DW, Lim YS, Yu ML, Nguyen MH.

Aliment Pharmacol Ther. 2018 Jul;48(1):44-54. doi: 10.1111/apt.14801. Epub 2018 May 24.

PMID:
29797518
35.

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C.

Batsaikhan B, Huang CI, Yeh ML, Huang CF, Hou NJ, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL, Lee JC, Dai CY.

Oncotarget. 2018 Apr 20;9(30):21313-21321. doi: 10.18632/oncotarget.25092. eCollection 2018 Apr 20.

36.

Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients.

Batsaikhan B, Huang CI, Yeh ML, Huang CF, Liang PC, Hsieh MY, Huang JF, Yu ML, Chuang WL, Lee JC, Lee PL, Dai CY.

J Gastroenterol Hepatol. 2018 Nov;33(11):1897-1903. doi: 10.1111/jgh.14275. Epub 2018 Jun 3.

PMID:
29737561
37.

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C.

Yeh ML, Huang CI, Huang CF, Hsieh MH, Hsieh MY, Lin ZY, Chen SC, Huang JF, Kuo PL, Kuo HT, Dai CY, Yu ML, Chuang WL.

Oncotarget. 2018 Jan 13;9(15):12240-12249. doi: 10.18632/oncotarget.24219. eCollection 2018 Feb 23.

38.

The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection.

Dai CY, Tsai YS, Chou WW, Liu T, Huang CF, Wang SC, Tsai PC, Yeh ML, Hsieh MY, Huang CI, Vanson Liu SY, Huang JF, Chuang WL, Yu ML.

Oncotarget. 2018 Jan 10;9(13):11291-11302. doi: 10.18632/oncotarget.24129. eCollection 2018 Feb 16.

39.

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.

Huang CI, Huang CF, Yeh ML, Lin YH, Liang PC, Liu SV, Hsieh MH, Lin ZY, Chen SC, Huang JF, Chuang WL, Dai CY, Yu ML.

Medicine (Baltimore). 2018 Mar;97(10):e9782. doi: 10.1097/MD.0000000000009782.

40.

Detection of membrane protein-protein interaction in planta based on dual-intein-coupled tripartite split-GFP association.

Liu TY, Chou WC, Chen WY, Chu CY, Dai CY, Wu PY.

Plant J. 2018 May;94(3):426-438. doi: 10.1111/tpj.13874. Epub 2018 Mar 23.

41.

Publisher Correction: Affinity purification of cell-specific mitochondria from whole animals resolves patterns of genetic mosaicism.

Ahier A, Dai CY, Tweedie A, Bezawork-Geleta A, Kirmes I, Zuryn S.

Nat Cell Biol. 2018 Mar;20(3):361. doi: 10.1038/s41556-018-0055-x.

PMID:
29449617
42.

microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings.

Fang C, Dai CY, Mei Z, Jiang MJ, Gu DN, Huang Q, Tian L.

J Exp Clin Cancer Res. 2018 Feb 13;37(1):25. doi: 10.1186/s13046-018-0697-3.

43.

Eudesmanolides and Other Constituents from the Flowers of Wedelia trilobata.

Hui Y, Cao J, Lin J, Yang JN, Liu YJ, Han CR, Song XP, Dai CY, Zhang XP, Chen WH, Chen GY.

Chem Biodivers. 2018 Mar;15(3):e1700411. doi: 10.1002/cbdv.201700411. Epub 2018 Mar 5.

PMID:
29369483
44.

Affinity purification of cell-specific mitochondria from whole animals resolves patterns of genetic mosaicism.

Ahier A, Dai CY, Tweedie A, Bezawork-Geleta A, Kirmes I, Zuryn S.

Nat Cell Biol. 2018 Mar;20(3):352-360. doi: 10.1038/s41556-017-0023-x. Epub 2018 Jan 22. Erratum in: Nat Cell Biol. 2018 Feb 15;:.

PMID:
29358705
45.

Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection.

Dai CY, Lin CY, Tsai PC, Lin PY, Yeh ML, Huang CF, Chang WT, Huang JF, Yu ML, Chen YL.

J Chin Med Assoc. 2018 Feb;81(2):155-163. doi: 10.1016/j.jcma.2017.06.018. Epub 2017 Dec 6.

46.

The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma.

Lin CW, Lin CC, Lee PH, Lo GH, Hsieh PM, Koh KW, Lee CY, Chen YL, Dai CY, Huang JF, Chuang WL, Chen YS, Yu ML.

Oncotarget. 2017 Aug 1;8(54):91902-91913. doi: 10.18632/oncotarget.19763. eCollection 2017 Nov 3.

47.

LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.

Sun XX, Zhang SS, Dai CY, Peng J, Pan Q, Xu LF, Ma XL.

Cell Physiol Biochem. 2017;44(3):1093-1105. doi: 10.1159/000485415. Epub 2017 Nov 27.

48.

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C.

Liang PC, Lin PC, Huang CI, Huang CF, Yeh ML, Zeng YS, Hsu WY, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chiou SS, Yu ML.

J Formos Med Assoc. 2018 Jan;117(1):14-23. doi: 10.1016/j.jfma.2017.10.001. Epub 2017 Oct 31.

49.

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents.

Huang JF, Huang CF, Yeh ML, Dai CY, Hsieh MH, Yang JF, Huang CI, Lin YH, Liang PC, Lin ZY, Chen SC, Yu ML, Chuang WL.

Kaohsiung J Med Sci. 2017 Nov;33(11):567-571. doi: 10.1016/j.kjms.2017.07.003. Epub 2017 Aug 5.

50.

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.

Jun TW, Yeh ML, Yang JD, Chen VL, Nguyen P, Giama NH, Huang CF, Hsing AW, Dai CY, Huang JF, Chuang WL, Roberts LR, Yu ML, Nguyen MH.

Liver Int. 2018 May;38(5):895-902. doi: 10.1111/liv.13613. Epub 2017 Nov 3.

Supplemental Content

Support Center